HF 4 Minnesota House · 2019-2020 Regular Session

Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify the attorney general of certain prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers related to price increases; civil penalties imposed; and money appropriated.

Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2019
Committee Review
Floor Vote
Governor
Introduced Jan 10, 2019 Last action Mar 26, 2020
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
10
Key actions
5
Committee
6
Amendments
1
Mar 26, 2020
Lower · Passed
Committee report, without further rec to amend, re-refer to Ways and Means
lower
Mar 11, 2020
Lower · Passed
Committee report, without further rec to amend, re-refer to State Government Finance Division
lower
Feb 27, 2020
Introduced
Division action, to adopt as amended and return to Ways and Means
lower
Mar 4, 2019
Committee
Referred by Chair to Health and Human Services Finance Division
lower
Mar 4, 2019
Lower · Passed
Committee report, to adopt and re-refer to Ways and Means
lower
Feb 21, 2019
Lower · Passed
Committee report, to adopt as amended and re-refer to Judiciary Finance and Civil Law Division
lower
Feb 7, 2019
Lower · Passed
Committee report, to adopt as amended and re-refer to Commerce
lower
Jan 10, 2019
Introduced
Introduction and first reading, referred to Health and Human Services Policy
lower
1 primary · 29 co-sponsors

Sponsors